We are live on !
Find out more
Boston Trust Walden Portfolio holdings
AUM
$13.1B
Turnover
6.42%
1-Year Est. Return
24.63%
This Fund
S&P 500
This Quarter Est. Return
-11.97%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$10.6B
AUM Growth
-$1.52B
(-13%)
Cap. Flow
+$47.1M
Cap. Flow % of AUM
Cap. Flow %
0.44%
Top 10 Holdings %
Top 10 Hldgs %
18.51%
Holding
395
New
8
Increased
194
Reduced
112
Closed
28
Avg Time Held
5.7
years
Top 10 Avg Time Held
3.8
years
Top 20 Avg Time Held
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Core Laboratories
CLB
|
+$53M |
| 2 |
Aspen Technology Inc
AZPN
|
+$36M |
| 3 |
Americold
COLD
|
+$32.5M |
| 4 |
Agilent Technologies
A
|
+$31M |
| 5 |
Teleflex
TFX
|
+$20.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASPEN TECHNOLOGY INC
AZPN
|
+$66.2M |
| 2 |
M&T Bank
MTB
|
+$43.8M |
| 3 |
Baker Hughes
BKR
|
+$38.3M |
| 4 |
Oracle
ORCL
|
+$36.5M |
| 5 |
CDK
CDK Global, Inc.
CDK
|
+$35.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.35% |
| 2 | Healthcare | 17.05% |
| 3 | Financials | 15.67% |
| 4 | Industrials | 13.84% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Northern Trust
NTRS
$30.3B
| $85.1M | 0.8% |
881,964
+1,134
| +0.1% | +$120K |
2013 Q2
36 quarters
|
|
27
Comcast
CMCSA
$77.7B
| $84.7M | 0.8% |
2,157,679
+39,842
| +2% | +$1.71M |
2013 Q2
36 quarters
|
|
28
Dollar General
DG
$29.6B
| $82.2M | 0.78% |
335,063
-475
| -0.1% | -$111K |
2015 Q2
28 quarters
|
|
29
T. Rowe Price
TROW
$21.5B
| $81M | 0.77% |
713,277
+8,481
| +1% | +$1.08M |
2013 Q2
36 quarters
|
|
30
Stryker
SYK
$113B
| $80.9M | 0.76% |
406,769
+126
| +0% | +$29.6K |
2013 Q2
36 quarters
|
|
31
Eversource Energy
ES
$25.2B
| $80.1M | 0.76% |
948,131
-13,988
| -1% | -$1.24M |
2013 Q2
36 quarters
|
|
32
Air Products & Chemicals
APD
$66.7B
| $79.1M | 0.75% |
328,936
+50,669
| +18% | +$12.3M |
2014 Q1
33 quarters
|
|
33
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $78.9M | 0.75% |
4,520,719
+88,058
| +2% | +$1.55M |
2020 Q3
7 quarters
|
|
34
Helmerich & Payne
HP
$3.74B
| $77.9M | 0.74% |
1,809,982
-167,712
| -8% | -$7.79M |
2017 Q1
21 quarters
|
|
35
Chubb
CB
$139B
| $75.8M | 0.72% |
385,762
+3,553
| +0.9% | +$732K |
2016 Q1
25 quarters
|
|
36
Flowers Foods
FLO
$1.3B
| $75.6M | 0.71% |
2,871,103
+34,802
| +1% | +$916K |
2014 Q3
31 quarters
|
|
37
East-West Bancorp
EWBC
$17.4B
| $75.2M | 0.71% |
1,159,997
+57,522
| +5% | +$4.13M |
2013 Q2
36 quarters
|
|
38
Cooper Companies
COO
$11B
| $73.4M | 0.69% |
938,256
+70,256
| +8% | +$6.22M |
2014 Q1
33 quarters
|
|
39
Merck
MRK
$360B
| $73.3M | 0.69% |
804,492
-14,423
| -2% | -$1.28M |
2013 Q2
36 quarters
|
|
40
ConocoPhillips
COP
$176B
| $72.3M | 0.68% |
804,839
-85,155
| -10% | -$8.77M |
2013 Q2
36 quarters
|
|
41
UMB Financial
UMBF
$10B
| $71.9M | 0.68% |
835,500
+12,904
| +2% | +$1.17M |
2013 Q2
36 quarters
|
|
42
Progress Software
PRGS
$1.67B
| $71.6M | 0.68% |
1,580,601
+176,432
| +13% | +$8.4M |
2019 Q1
13 quarters
|
|
43
Columbia Sportswear
COLM
$3.08B
| $71.5M | 0.68% |
998,765
+33,331
| +3% | +$2.66M |
2020 Q3
7 quarters
|
|
44
Applied Industrial Technologies
AIT
$12.1B
| $69.9M | 0.66% |
726,748
+9,928
| +1% | +$1M |
2015 Q1
29 quarters
|
|
45
Choice Hotels
CHH
$4.88B
| $67M | 0.63% |
600,156
+9,008
| +2% | +$1.17M |
2014 Q3
31 quarters
|
|
46
Masco
MAS
$14.4B
| $66.5M | 0.63% |
1,314,304
+13,369
| +1% | +$707K |
2019 Q1
13 quarters
|
|
47
ONE Gas
OGS
$4.75B
| $66.2M | 0.63% |
815,573
+13,097
| +2% | +$1.12M |
2014 Q3
31 quarters
|
|
48
Ross Stores
ROST
$75.7B
| $64.5M | 0.61% |
918,499
+15,600
| +2% | +$1.39M |
2013 Q2
36 quarters
|
|
49
Cisco
CSCO
$423B
| $63.4M | 0.6% |
1,485,779
-10,859
| -0.7% | -$520K |
2013 Q2
36 quarters
|
|
50
ExxonMobil
XOM
$736B
| $63.3M | 0.6% |
739,478
+76,792
| +12% | +$6.93M |
2013 Q2
36 quarters
|
|
Similar funds
Boston Trust Walden's Q2 2022 Portfolio in Review
As of Q2 2022, Boston Trust Walden held 395 positions worth $10.6B, down 13% from $12.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Boston Trust Walden's Q2 2022 filing shows 8 new, 194 increased, 112 reduced and 28 closed positions. Its largest new stake was Core Laboratories: 1,993,528 shares worth $39.5M. The largest sale was ASPEN TECHNOLOGY INC, an estimated $66.2M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Boston Trust Walden's largest Q2 2022 buy was Core Laboratories: 1,993,528 shares worth $39.5M.
- Boston Trust Walden added most to Americold in Q2 2022, an estimated $32.5M increase.
- Boston Trust Walden's biggest Q2 2022 reduction was M&T Bank, cutting an estimated $43.8M.
- Boston Trust Walden fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $66.2M.
- Boston Trust Walden's ten largest holdings make up 19% of its $10.6B portfolio in Q2 2022.
- Boston Trust Walden opened 8 new positions and closed 28 in Q2 2022.
- Boston Trust Walden's portfolio value fell 13% quarter-over-quarter to $10.6B.
Based on Boston Trust Walden's 13F filing for Q2 2022, filed 22 Jul 2022.